The EASL Liver Cancer Summit 2025 will take place in Paris from February 20-22, bringing together leading experts to discuss the latest developments in liver cancer diagnosis, prognosis, and treatment. Rocío Macías, Fabio Piscaglia, and Julien Calderaro emphasized that this year’s summit is an important opportunity to explore new research, therapies, and experimental models that are reshaping the field.
A key highlight of the meeting is Cholangiocarcinoma Day, dedicated to raising awareness of this aggressive and often overlooked type of liver cancer. With new drugs and treatment options emerging, the landscape for HCC, cholangiocarcinoma, and rare liver tumors is evolving, offering new possibilities for patient care.
The program will feature discussions on advancements in liver cancer research and an abstract session focused entirely on scientific communication. Experts attending will gain valuable insights that can help refine treatment approaches and improve patient outcomes.
Abstract submissions are now open, making this an excellent opportunity to share research and contribute to shaping the future of liver cancer treatment.
Looking forward to seeing everyone in Paris for this important event!
For more information: https://lnkd.in/ecedhYtW
